neuroconcise ltd.
neuroconcise ltd. Company Information
Company Number
NI642461
Website
-Registered Address
c-tric altnagalvin hospital camp, glenshane road, derry, co derry, BT47 6SB
Industry
Research and experimental development on biotechnology
Other human health activities
Telephone
-
Next Accounts Due
14 days late
Group Structure
View All
Shareholders
damien coyle 77.3%
innovation ulster limited 14.3%
View Allneuroconcise ltd. Estimated Valuation
Pomanda estimates the enterprise value of NEUROCONCISE LTD. at £83.8k based on a Turnover of £129.8k and 0.65x industry multiple (adjusted for size and gross margin).
neuroconcise ltd. Estimated Valuation
Pomanda estimates the enterprise value of NEUROCONCISE LTD. at £152k based on an EBITDA of £39.9k and a 3.81x industry multiple (adjusted for size and gross margin).
neuroconcise ltd. Estimated Valuation
Pomanda estimates the enterprise value of NEUROCONCISE LTD. at £0 based on Net Assets of £-27.3k and 2.34x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Neuroconcise Ltd. Overview
Neuroconcise Ltd. is a live company located in derry, BT47 6SB with a Companies House number of NI642461. It operates in the manufacture of professional and arcade games and toys sector, SIC Code 32401. Founded in November 2016, it's largest shareholder is damien coyle with a 77.3% stake. Neuroconcise Ltd. is a young, micro sized company, Pomanda has estimated its turnover at £129.8k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Neuroconcise Ltd. Health Check
Pomanda's financial health check has awarded Neuroconcise Ltd. a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
1 Strong
2 Regular
7 Weak
Size
annual sales of £129.8k, make it smaller than the average company (£8.2m)
- Neuroconcise Ltd.
£8.2m - Industry AVG
Growth
3 year (CAGR) sales growth of -22%, show it is growing at a slower rate (6.6%)
- Neuroconcise Ltd.
6.6% - Industry AVG
Production
with a gross margin of 25.4%, this company has a higher cost of product (39.1%)
- Neuroconcise Ltd.
39.1% - Industry AVG
Profitability
an operating margin of 30.8% make it more profitable than the average company (4.7%)
- Neuroconcise Ltd.
4.7% - Industry AVG
Employees
with 1 employees, this is below the industry average (51)
1 - Neuroconcise Ltd.
51 - Industry AVG
Pay Structure
on an average salary of £47.5k, the company has an equivalent pay structure (£47.5k)
- Neuroconcise Ltd.
£47.5k - Industry AVG
Efficiency
resulting in sales per employee of £129.8k, this is equally as efficient (£128.8k)
- Neuroconcise Ltd.
£128.8k - Industry AVG
Debtor Days
it gets paid by customers after 163 days, this is later than average (50 days)
- Neuroconcise Ltd.
50 days - Industry AVG
Creditor Days
its suppliers are paid after 23 days, this is quicker than average (37 days)
- Neuroconcise Ltd.
37 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Neuroconcise Ltd.
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Neuroconcise Ltd.
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 146.9%, this is a higher level of debt than the average (42.8%)
146.9% - Neuroconcise Ltd.
42.8% - Industry AVG
NEUROCONCISE LTD. financials
Neuroconcise Ltd.'s latest turnover from December 2022 is estimated at £129.8 thousand and the company has net assets of -£27.3 thousand. According to their latest financial statements, Neuroconcise Ltd. has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Nov 2019 | Nov 2018 | Nov 2017 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | 1 | 1 | 3 | 3 | ||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Nov 2019 | Nov 2018 | Nov 2017 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 2 | 2 | 2 | 997 | 1,997 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 2 | 2 | 2 | 997 | 1,997 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 58,223 | 22,353 | 64,883 | 103,719 | 69,826 | 20,168 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 58,223 | 22,353 | 64,883 | 103,719 | 69,826 | 20,168 |
| total assets | 58,225 | 22,355 | 64,885 | 104,716 | 71,823 | 20,168 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 6,157 | 2,644 | 8,483 | 12,424 | 1,111 | 26,078 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 6,157 | 2,644 | 8,483 | 12,424 | 1,111 | 26,078 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 79,400 | 79,400 | 79,400 | 79,400 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 79,400 | 79,400 | 79,400 | 79,400 | 0 | 0 |
| total liabilities | 85,557 | 82,044 | 87,883 | 91,824 | 1,111 | 26,078 |
| net assets | -27,332 | -59,689 | -22,998 | 12,892 | 70,712 | -5,910 |
| total shareholders funds | -27,332 | -59,689 | -22,998 | 12,892 | 70,712 | -5,910 |
| Dec 2022 | Dec 2021 | Dec 2020 | Nov 2019 | Nov 2018 | Nov 2017 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | 0 | 0 | 0 | |||
| Amortisation | 0 | 0 | 0 | |||
| Tax | ||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 35,870 | -42,530 | -38,836 | 33,893 | 49,658 | 20,168 |
| Creditors | 3,513 | -5,839 | -3,941 | 11,313 | -24,967 | 26,078 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 79,400 | 0 | 0 |
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 |
neuroconcise ltd. Credit Report and Business Information
Neuroconcise Ltd. Competitor Analysis
Perform a competitor analysis for neuroconcise ltd. by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in BT47 area or any other competitors across 12 key performance metrics.
neuroconcise ltd. Ownership
NEUROCONCISE LTD. group structure
Neuroconcise Ltd. has no subsidiary companies.
Ultimate parent company
NEUROCONCISE LTD.
NI642461
neuroconcise ltd. directors
Neuroconcise Ltd. currently has 3 directors. The longest serving directors include Dr Damien Coyle Damien Coyle (Nov 2016) and Mr Timothy Brundle (Nov 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Damien Coyle Damien Coyle | 44 years | Nov 2016 | - | Director | |
| Mr Timothy Brundle | 51 years | Nov 2017 | - | Director | |
| Dr David McBride | 63 years | Jun 2019 | - | Director |
P&L
December 2022turnover
129.8k
+134%
operating profit
39.9k
0%
gross margin
25.5%
+14.72%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
-27.3k
-0.54%
total assets
58.2k
+1.6%
cash
0
0%
net assets
Total assets minus all liabilities
neuroconcise ltd. company details
company number
NI642461
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
86900 - Other human health activities
32401 - Manufacture of professional and arcade games and toys
incorporation date
November 2016
age
8
incorporated
UK
accounts
Micro-Entity Accounts
ultimate parent company
previous names
N/A
last accounts submitted
December 2022
address
c-tric altnagalvin hospital camp, glenshane road, derry, co derry, BT47 6SB
accountant
-
auditor
-
neuroconcise ltd. Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to neuroconcise ltd..
neuroconcise ltd. Companies House Filings - See Documents
| date | description | view/download |
|---|
